Novo Holdings A/S - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$3,019,000
-45.8%
847,906
-39.0%
0.13%
-53.4%
Q3 2020$5,572,000
-30.0%
1,389,498
-52.5%
0.28%
-46.1%
Q2 2020$7,963,000
+28.9%
2,927,5600.0%0.51%
+24.8%
Q1 2020$6,177,000
-61.2%
2,927,5600.0%0.41%
-59.8%
Q4 2019$15,926,000
+80.7%
2,927,5600.0%1.03%
-32.1%
Q3 2019$8,812,000
-46.7%
2,927,560
-33.8%
1.51%
-34.8%
Q2 2019$16,533,000
-7.0%
4,420,5160.0%2.32%
-11.9%
Q1 2019$17,770,000
+9.5%
4,420,5160.0%2.63%
+15.1%
Q4 2018$16,223,000
-57.2%
4,420,5160.0%2.28%
-24.1%
Q3 2018$37,928,000
-21.9%
4,420,5160.0%3.01%
-38.3%
Q2 2018$48,537,000
-4.8%
4,420,5160.0%4.88%
-23.7%
Q1 2018$50,969,000
+51.7%
4,420,516
+36.3%
6.39%
+35.7%
Q4 2017$33,608,000
-35.0%
3,244,0460.0%4.71%
-30.0%
Q3 2017$51,710,000
+31.7%
3,244,0460.0%6.73%
+43.3%
Q2 2017$39,253,000
-41.4%
3,244,046
+0.6%
4.70%
-34.1%
Q1 2017$66,963,000
+45.2%
3,224,0460.0%7.13%
+62.4%
Q4 2016$46,104,000
-13.1%
3,224,0460.0%4.39%
-6.8%
Q3 2016$53,036,000
+15.4%
3,224,0460.0%4.71%
-2.4%
Q2 2016$45,975,000
+0.5%
3,224,046
+2.2%
4.83%
-3.7%
Q1 2016$45,734,0003,154,0465.01%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$8,746,0001.82%
Telemetry Investments, L.L.C. 263,975$705,0000.97%
CHI Advisors LLC 719,132$1,920,0000.45%
BVF INC/IL 3,678,626$9,822,0000.37%
EcoR1 Capital, LLC 3,579,377$9,557,0000.36%
Orbimed Advisors 8,053,298$21,502,0000.22%
Stonepine Capital Management, LLC 46,886$125,0000.06%
Ikarian Capital, LLC 100,000$267,0000.02%
ALGERT GLOBAL LLC 19,737$53,0000.02%
Windsor Creek Advisors, LLC 14,786$39,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders